World's Best Scientists 2026 revealed!
Claire E. Wainwright

Claire E. Wainwright

D-Index & Metrics

Biology and Biochemistry

D-Index
53
Citations
14470
World Ranking
15959
National Ranking
446

Claire E. Wainwright publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Claire E. Wainwright sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 275 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Claire E. Wainwright D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Claire E. Wainwright sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 53 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Claire E. Wainwright is affiliated with the University of Queensland in Australia and has a research focus primarily within the field of Medicine, with significant contributions to Pulmonary and Respiratory Medicine.

The scientist's work has extensively covered various subfields including Epidemiology, Emergency Medical Services, Infectious Diseases, and Molecular Biology. Their research topics span several areas such as Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research, Tracheal and Airway Disorders, Mycobacterium Research and Diagnosis, Pediatric Health and Respiratory Diseases, Respiratory Viral Infections Research, and Tuberculosis Research and Epidemiology.

Frequent publication venues for their work include:

  • Journal of Cystic Fibrosis
  • American Journal of Respiratory and Critical Care Medicine
  • The Lancet Respiratory Medicine
  • SSRN Electronic Journal
  • Scientific Reports

Their recent papers include:

  • A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele, 2021, American Journal of Respiratory and Critical Care Medicine
  • Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study, 2022, American Journal of Respiratory and Critical Care Medicine
  • Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial, 2020, American Journal of Respiratory and Critical Care Medicine
  • Nebulised hypertonic saline solution for acute bronchiolitis in infants, 2023, Cochrane Database of Systematic Reviews
  • A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation, 2020, Journal of Cystic Fibrosis

Collaborators frequently working alongside Claire E. Wainwright include:

  • Scott C. Bell
  • Peter D. Sly
  • Jane C. Davies
  • Keith Grimwood
  • Neil Ahluwalia

Best Publications

  • A CFTR potentiator in patients with cystic fibrosis and the G551D mutation

    Bonnie W. Ramsey;Jane Davies;N. Gerard McElvaney;Elizabeth Tullis

  • Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.

    Josephine M Bryant;Josephine M Bryant;Dorothy M Grogono;Dorothy M Grogono;Daniela Rodriguez-Rincon;Isobel Everall

  • Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation

    Jane C. Davies;Jane C. Davies;Claire E. Wainwright;Gerard J. Canny;Mark A. Chilvers

  • Determination of the Minimal Clinically Important Difference Scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in Two Populations of Patients With Cystic Fibrosis and Chronic Pseudomonas aeruginosa Airway Infection

    Alexandra L. Quittner;Avani C. Modi;Claire Wainwright;Kelly Otto

  • A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis.

    Claire Wainwright;Luis Altamirano;Marise Cheney;Joyce Cheney

  • Genetic modifiers of liver disease in cystic fibrosis.

    Jaclyn R. Bartlett;Kenneth J. Friedman;Simon C. Ling;Rhonda G. Pace

  • Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study

    Margaret Rosenfeld;Claire E Wainwright;Mark Higgins;Linda T Wang

  • Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)

    Edward F McKone;Drucy Borowitz;Pavel Drevinek;Matthias Griese;Matthias Griese

  • Drivers of seedling establishment success in dryland restoration efforts.

    Nancy Shackelford;Nancy Shackelford;Gustavo B. Paterno;Gustavo B. Paterno;Daniel E. Winkler;Todd E. Erickson

  • Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: A randomized trial

    Claire E. Wainwright;Suzanna Vidmar;David S. Armstrong;Catherine A. Byrnes

  • A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele.

    Edith T. Zemanick;Jennifer L. Taylor-Cousar;Jane Davies;Ronald L. Gibson

  • Seasonal priority effects: implications for invasion and restoration in a semi-arid system.

    Claire E. Wainwright;Elizabeth M. Wolkovich;Elsa E. Cleland

  • Rapid genotyping of Pseudomonas aeruginosa isolates harboured by adult and paediatric patients with cystic fibrosis using repetitive-element-based PCR assays.

    Melanie W Syrmis;Mark R O'Carroll;Theo P Sloots;Chris Coulter

  • Comparison of DNA extraction methods for microbial community profiling with an application to pediatric bronchoalveolar lavage samples.

    Dana Willner;Joshua Daly;David Whiley;David Whiley;Keith Grimwood;Keith Grimwood

  • Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis

    Claire E Wainwright;Peter O'Rourke;Snehal Anuj

  • Acute viral bronchiolitis in children- a very common condition with few therapeutic options

    Claire Wainwright

  • Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units

    M.R. O'Carroll;M.W. Syrmis;C.E. Wainwright;R.M. Greer

  • Early airway infection, inflammation, and lung function in cystic fibrosis

    G M Nixon;D S Armstrong;R Carzino;J B Carlin

  • Phenotypic Characterization of Clonal and Nonclonal Pseudomonas aeruginosa Strains Isolated from Lungs of Adults with Cystic Fibrosis

    Pholawat Tingpej;Lucas Smith;Barbara Rose;Hua Zhu

  • Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

    J. M. Bryant;D. M. Grogono;D. Rodriguez-Rincon;I. Everall

Frequent Co-Authors

Scott C. Bell
Scott C. Bell University of Queensland
Keith Grimwood
Keith Grimwood Griffith University
Peter D. Sly
Peter D. Sly University of Queensland
Michael D. Nissen
Michael D. Nissen University of Queensland
John B. Carlin
John B. Carlin University of Melbourne
Theo P. Sloots
Theo P. Sloots University of Queensland
Colin F. Robertson
Colin F. Robertson Royal Children's Hospital
Luke D. Knibbs
Luke D. Knibbs University of Sydney
David M. Whiley
David M. Whiley University of Queensland
Lidia Morawska
Lidia Morawska Queensland University of Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens the door to diverse career opportunities, many of which can be pursued with flexible online degrees. One popular pathway is medical coding, which uses knowledge of biology to accurately manage patient data. Those interested in this role often research topics like medical coding jobs salary to understand earning potential and job outlook.

Aspiring professionals should also consider the pros and cons associated with this field. If you’re wondering, is medical coding a good career, it’s essential to weigh factors such as job stability, remote work options, and the need for certification or additional training.

For those looking to expand beyond coding, a variety of health information management online programs offer affordable and accredited options to advance your education. Additionally, if you have an interest in nutrition or health sciences, pursuing an online masters degree in nutrition can lead to specialized roles in wellness, education, and clinical settings.

Best Scientists Citing Claire E. Wainwright

Trending Scientists

Recently Published Articles